Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

28
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
28
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Lineage Commitment01:21

Lineage Commitment

3.0K
Commitment is the  process whereby stem cells:
3.0K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

352
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
352
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Change of Cervical Cancer Stage at Diagnosis After the COVID-19 Pandemic.

Cureus·2026
Same author

Outpatient Delivery of Step-Up Doses to Rapidly Initiate Monthly Doses of Bispecific Antibodies in Multiple Myeloma.

European journal of haematology·2026
Same author

Tuberculosis reactivation in hematopoietic stem cell transplant recipients: a preemptive strategy in an endemic country.

Journal of clinical tuberculosis and other mycobacterial diseases·2025
Same author

Subgroup analysis of treatment pathways and clinical outcomes in Hodgkin lymphoma in Latin America from the retrospective B-HOLISTIC study.

Scientific reports·2025
Same author

Development of Polyvinyl Alcohol Hydrogels for Controlled Glucose Release in Biomedical Applications.

Gels (Basel, Switzerland)·2024
Same author

Impact of a guaranteed access program to imatinib on the survival of patients with chronic myeloid leukemia.

Cancer causes & control : CCC·2024

Related Experiment Video

Updated: Jul 16, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.4K

First inter-institutional consensus on Chronic Myeloproliferative Neoplasms.

Gilberto Barranco-Lampón1,2, Raúl Martínez-Castro3, Luara Arana-Luna4

  • 1Servicio de Hematología, Hospital General de México, Ciudad de México, México.

Gaceta Medica De Mexico
|September 21, 2023
PubMed
Summary

This consensus provides updated diagnostic and treatment information for chronic myeloproliferative neoplasms (MPNs) to Mexican healthcare professionals. It aims to unify clinical practice and improve patient care nationwide.

Keywords:
ConsensoConsensusDiagnosisDiagnósticoMyeloproliferative neoplasmNeoplasia mieloproliferativa

More Related Videos

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

11.7K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

167

Related Experiment Videos

Last Updated: Jul 16, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.4K
Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

11.7K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

167

Area of Science:

  • Hematology
  • Oncology
  • Public Health

Background:

  • Chronic myeloproliferative neoplasms (MPNs) require standardized diagnostic and treatment protocols.
  • Varied clinical practices exist across different public health institutions in Mexico.

Purpose of the Study:

  • To provide updated, relevant information on MPN diagnosis and treatment to healthcare professionals.
  • To unify diagnostic and treatment criteria for myeloproliferative diseases nationwide.
  • To enhance the quality of care for MPN patients across the Mexican Republic.

Main Methods:

  • Inter-institutional consensus development.
  • Review of current clinical practice guidelines and evidence.
  • Expert panel discussions and agreement on recommendations.

Main Results:

  • A unified set of recommendations for the diagnosis of MPNs.
  • Standardized treatment protocols for various myeloproliferative diseases.
  • Dissemination of consensus guidelines to public health institutions.

Conclusions:

  • The consensus provides a crucial resource for healthcare professionals managing MPNs.
  • Standardization of care is expected to improve patient outcomes in Mexico.
  • This initiative promotes evidence-based practice in hematologic oncology.